America’s biopharmaceutical companies stand with everyone affected by the terrible COVID-19 surge in India and patients around the world.

Biopharmaceutical companies are working around the clock to meet the demands of COVID-19 by developing and delivering therapeutics and vaccines. Companies are also providing financial support and in-kind donations to organizations, building capacity with Indian manufacturers, entering into licensing agreements, supporting frontline workers and collaborating with global health authorities to combat this public health crisis.